HK1068105A1 - Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof - Google Patents

Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof

Info

Publication number
HK1068105A1
HK1068105A1 HK05101747.9A HK05101747A HK1068105A1 HK 1068105 A1 HK1068105 A1 HK 1068105A1 HK 05101747 A HK05101747 A HK 05101747A HK 1068105 A1 HK1068105 A1 HK 1068105A1
Authority
HK
Hong Kong
Prior art keywords
oxazolin
composition
cell migration
langerhans cell
inhibiting
Prior art date
Application number
HK05101747.9A
Other languages
English (en)
Chinese (zh)
Inventor
Antoine Piccirilli
Nathalie Piccardi
Philippe Msika
Original Assignee
Expanscience Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Expanscience Lab filed Critical Expanscience Lab
Publication of HK1068105A1 publication Critical patent/HK1068105A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
HK05101747.9A 2001-12-27 2005-03-01 Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof HK1068105A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116917A FR2834216B1 (fr) 2001-12-27 2001-12-27 Composition cosmetique ou pharmaceutique comprenant au moins une oxazoline pour inhiber la migration des cellules de langerhans, et ses utilisations
PCT/FR2002/004583 WO2003055463A1 (fr) 2001-12-27 2002-12-27 Composition comprenant au moins une oxazoline pour inhiber la migration des cellules de langerhans, et ses utilisations

Publications (1)

Publication Number Publication Date
HK1068105A1 true HK1068105A1 (en) 2005-04-22

Family

ID=8871016

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05101747.9A HK1068105A1 (en) 2001-12-27 2005-03-01 Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof

Country Status (12)

Country Link
US (2) US8236836B2 (xx)
EP (1) EP1458349B1 (xx)
JP (1) JP4767497B2 (xx)
KR (1) KR100900648B1 (xx)
CN (1) CN1617704B (xx)
AU (1) AU2002365026A1 (xx)
CA (1) CA2472190C (xx)
ES (1) ES2528675T3 (xx)
FR (1) FR2834216B1 (xx)
HK (1) HK1068105A1 (xx)
MX (1) MXPA04006418A (xx)
WO (1) WO2003055463A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674477A (en) * 1995-02-28 1997-10-07 Ahluwalia; Gurpreet S. Reduction of hair growth
FR2847473B1 (fr) 2002-11-25 2007-06-29 Expanscience Lab Composition comprenant au moins une oxazolidinone, son utilisation cosmetique et comme medicament
FR2856294B1 (fr) 2003-06-18 2005-08-05 Expanscience Lab Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
JP2006206538A (ja) * 2005-01-31 2006-08-10 Institute Of Physical & Chemical Research 抗原提示細胞の機能制御剤
FR2885128B1 (fr) * 2005-04-27 2007-07-06 Expanscience Laboratoires Sa Composition cosmetique a visee depigmentante ou eclaircissante comprenant au moins une oxazoline, a titre de principe actif depigmentant ou eclaircissant
EP1931624A1 (en) * 2005-08-31 2008-06-18 Serentis Limited Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus
FR2908650B1 (fr) * 2006-11-16 2012-05-25 Lvmh Rech Utilisation d'une alkyloxazolidinone comme agent cosmetique hydratant et procede d'hydratation de la peau.
FR2953722B1 (fr) 2009-12-16 2012-03-09 Expanscience Lab Composition comprenant au moins un sucre en c7 pour le traitement de l'alopecie, pour le traitement cosmetique des phaneres, et pour le soin des cheveux, cils ou ongles
ES2648188T3 (es) 2012-02-17 2017-12-29 Epitech Group S.P.A. Composiciones y métodos para la modulación de amidasas específicas para N-aciletanolaminas para ser usadas en la terapia de enfermedades inflamatorias
FR3068045B1 (fr) 2017-06-22 2021-06-04 Expanscience Lab Modeles de peau sensible reconstituee
CN108250162B (zh) * 2017-12-27 2021-06-22 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 一种医药中间体二芳基环氧乙烷化合物及其合成方法
FR3098394B1 (fr) * 2019-07-12 2022-07-08 Expanscience Lab Composition comprenant au moins une oxazoline pour inhiber la croissance de levure du genre Malassezia impliquée notamment dans les croûtes de lait

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2368075A (en) * 1943-09-11 1945-01-23 Commercial Solvents Corp Astringent preparations
US4345084A (en) * 1981-06-29 1982-08-17 Hoffmann-La Roche Inc. Unsaturated eicosanoic acids
US4876249A (en) * 1987-01-12 1989-10-24 Rajadhyaksha Vithal J Compositions and method comprising heterocyclic compounds containing two heteroatoms
US5360811A (en) * 1990-03-13 1994-11-01 Hoechst-Roussel Pharmaceuticals Incorporated 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds as anti-inflammatory agents
EP0741562A1 (en) * 1994-11-28 1996-11-13 Gist-Brocades B.V. Topical application of ceramides
US5955092A (en) * 1996-09-27 1999-09-21 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing an n-substituted fatty acid amide and retinol or retinyl ester
JPH1121247A (ja) * 1997-06-30 1999-01-26 Lion Corp 皮膚賦活剤及びアレルギー抑制剤
EP0908179A1 (en) * 1997-08-23 1999-04-14 Werner Bollag Treatment of cell-mediated immune diseases
KR100639531B1 (ko) * 1997-12-05 2006-10-27 코스모페름 베.파우 유리 스핑고이드 염기 및 세라미드의 조합으로 이루어지는 조성물 및 그것의 제조방법
WO1999043330A1 (fr) * 1998-02-26 1999-09-02 Chugai Seiyaku Kabushiki Kaisha Inhibiteurs de migration de cellules de langerhans
FR2792202B1 (fr) * 1999-04-19 2003-06-13 Pharmascience Lab Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait
JP2001064192A (ja) * 1999-08-25 2001-03-13 Sunstar Inc ランゲルハンス細胞の遊走抑制剤及び抗原提示抑制剤
US6369032B1 (en) * 2000-09-06 2002-04-09 Ortho-Mcneil Pharmaceutical, Inc. Method for treating allergies
AU2002314944B2 (en) * 2001-06-08 2008-03-06 Cytokine Pharmasciences, Inc. Isoxazoline compounds having MIF antagonist activity

Also Published As

Publication number Publication date
FR2834216A1 (fr) 2003-07-04
MXPA04006418A (es) 2004-11-10
EP1458349B1 (fr) 2014-11-05
CA2472190C (fr) 2012-04-24
US8653117B2 (en) 2014-02-18
US20090137453A1 (en) 2009-05-28
CA2472190A1 (fr) 2003-07-10
JP2005517671A (ja) 2005-06-16
KR100900648B1 (ko) 2009-06-02
FR2834216B1 (fr) 2004-04-30
CN1617704A (zh) 2005-05-18
CN1617704B (zh) 2011-10-05
AU2002365026A1 (en) 2003-07-15
EP1458349A1 (fr) 2004-09-22
US8236836B2 (en) 2012-08-07
JP4767497B2 (ja) 2011-09-07
WO2003055463A1 (fr) 2003-07-10
ES2528675T3 (es) 2015-02-11
KR20040095201A (ko) 2004-11-12
US20050075380A1 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
HK1068105A1 (en) Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof
HK1078004A1 (en) Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
EP1542699A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
AU2002234076A1 (en) Construction composition, structure, and method
HUP0200355A2 (en) 4-aminopyrrolopyrimidines as kinase inhibitors, pharmaceutical compositions containing them and their use
AU2003236527A8 (en) Compounds, compositions, and methods
AU2003265242A8 (en) Compounds, compositions, and methods
EP1578930A4 (en) CNGH0004 POLYPEPTIDES, ANTIBODIES, COMPOSITIONS, METHODS AND USES
AU2003270015A8 (en) Compounds, compositions, and methods
AU2003274211A8 (en) Flame-retardant composition, preparation method and use thereof
AU2003299612A8 (en) Compounds, compositions and methods
GB0026054D0 (en) Films,compositions and processes
AU4729699A (en) Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
GB9904021D0 (en) Polymer for photoresist,photoresist composition containing the same,and preparation method thereof
MXPA02003232A (es) Composiciones y metodos para alternar la expresion de genes.
EP1594521A4 (en) PEPTIDES THAT LIMIT ANGIOGENESIS, CELL WALKING, CELL INVASION AND CELL PROLIFERATION, AND THEIR COMPOSITIONS AND USES
GB9817236D0 (en) Compound,composition and use
EP1705740A4 (en) FUEL FOR FUEL CELL, FUEL CELL AND USE THEREOF
AU2003290507A8 (en) Compounds, compositions and methods
AU2002364348A8 (en) Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof
AU2003277079A8 (en) Compounds, compositions, and methods
AU2003251167A1 (en) Solid dispersion comprising amlodipine, method thereof and pharmaceutical composition comprising the solid dispersion
EP1539792A4 (en) CNGH0005 POLYPEPTIDES, ANTIBODIES, COMPOSITIONS, METHODS AND USES
GB9903447D0 (en) Compound, composition and use
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof

Legal Events

Date Code Title Description
AM Amended specification (according sect 146 of patent law)

Free format text: KRAFT FOODS R&D, INC. CORRECTION OF THE EP APPLICATION FILING DATE FROM 27.12.2001 TO 27.12.2002

Effective date: 20151223

PE Patent expired

Effective date: 20221226